Major myelin protein gene (P0) mutation causes a novel form of axonal degeneration

Journal of Comparative Neurology

Volumn 498, Issue 2, 2006, Pages 252-265

  Li, Jun ^a   Bai, Yunhong ^a   Ianakova, Emilia ^a   Grandis, Marina ^a   Uchwat, Fred ^b   Trostinskaia, Anna ^a   Krajewski, Karen M ^a   Garbern, James ^a   Kupsky, William J ^a   Shy, Michael E ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

Author keywords

Autopsy; Axonal degeneration; Intralaminar accumulation; Myelin protein zero; Schwann cell

Indexed keywords

AGED; ARTICLE; AUTOPSY; CASE REPORT; CLINICAL FEATURE; CYTOARCHITECTURE; FEMALE; GENE ISOLATION; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MYELIN SHEATH; NERVE FIBER DEGENERATION; PRIORITY JOURNAL; SCHWANN CELL; SCIATIC NERVE;

ADULT; AGED; ANIMALS; AUTOPSY; BIOLOGICAL MARKERS; CHARCOT-MARIE-TOOTH DISEASE; FEMALE; HUMANS; MUTATION; MYELIN P0 PROTEIN; MYELIN SHEATH; NERVE FIBERS, MYELINATED; PERIPHERAL NERVES; RETROGRADE DEGENERATION;

EID: 33746854437     PISSN: 00219967     EISSN: 10969861     Source Type: Journal    
DOI: 10.1002/cne.21051     Document Type: Article

References (59)

1. Archelos JJ, Roggenbuck K, Schneider-Schaulies J, Linington C, Toyka KV, Hartung HP. 1993. Production and characterization of monoclonal antibodies to the extracellular domain of P0. J Neurosci Res 35:46-53.
2. Arroyo EJ, Xu YT, Zhou L, Messing A, Peles E, Chiu SY, Scherer SS. 1999. Myelinating Schwann cells determine the internodal localization of Kv1.1, Kv1.2, Kvbeta2, and Caspr. J Neurocytol 28:333-347.
3. Arroyo EJ, Xu T, Grinspan J, Lambert S, Levinson SR, Brophy PJ, Peles E, Scherer SS. 2002. Genetic dysmyelination alters the molecular architecture of the nodal region. J Neurosci 22:1726-1737.
4. Arroyo EJ, Sirkowski EE, Chitale R, Scherer SS. 2004. Acute demyelination disrupts the molecular organization of peripheral nervous system nodes. J Comp Neurol 479:424-434.
5. Auer-Grumbach M, Strasser-Fuchs S, Robl T, Windpassinger C, Wagner K. 2003. Late onset Charcot-Marie-Tooth 2 syndrome caused by two novel mutations in the MPZ gene. Neurology 61:1435-1437.
6. Boyle ME, Berglund EO, Murai KK, Weber L, Peles E, Ranscht B. 2001. Contactin orchestrates assembly of the septate-like junctions at the paranode in myelinated peripheral nerve. Neuron 30:385-397.
7. Bunge RP, Bunge MB, Bates M. 1989. Movements of the Schwann cell nucleus implicate progression of the inner (axon-related) Schwann cell process during myelination. J Cell Biol 109:273-284.
8. De Jonghe P, Timmerman V, Ceuterick C, Nelis E, De Vriendt E, Lofgren A, Vercruyssen A, Verellen C, Van Maldergem L, Martin JJ, Van Broeckhoven C. 1999. The Thr124Met mutation in the peripheral myelin protein zero (MPZ) gene is associated with a clinically distinct Charcot-Marie-Tooth phenotype. Brain 122(Pt 2):281-290.
9. Deodato F, Sabatelli M, Ricci E, Mercuri E, Muntoni F, Sewry C, Naom I, Tonali P, Guzzetta F. 2002. Hypermyelinating neuropathy, mental retardation and epilepsy in a case of merosin deficiency. Neuromuscul Disord 12:392-398.
10. Devaux JJ, Scherer SS. 2005. Altered ion channels in an animal model of Charcot-Marie-Tooth disease type IA. J Neurosci 25:1470-1480.
11. Donaghy M, Sisodiya SM, Kennett R, McDonald B, Haites N, Bell C. 2000. Steroid responsive polyneuropathy in a family with a novel myelin protein zero mutation. J Neurol Neurosurg Psychiatry 69:799-805.
12. Dyck PJ, Griffin JW, Low PA, Poduslo JF. 1993. Peripheral neuropathy. Philadelphia: W.B. Saunders.
13. Einheber S, Zanazzi G, Ching W, Scherer S, Milner TA, Peles E, Salzer JL. 1997. The axonal membrane protein Caspr, a homologue of neurexin IV, is a component of the septate-like paranodal junctions that assemble during myelination. J Cell Biol 139:1495-1506.
14. Fabrizi GM, Cavallaro T, Taioli F, Orrico D, Morbin M, Simonati A, Rizzuto N. 1999. Myelin uncompaction in Charcot-Marie-Tooth neuropathy type 1A with a point mutation of peripheral myelin protein-22. Neurology 53:846-851.
15. Filbin MT, Zhang K, Li W, Gao Y. 1999. Characterization of the effect on adhesion of different mutations in myelin P0 protein. Ann N Y Acad Sci 883:160-167.
16. Fischer LR, Culver DG, Tennant P, Davis AA, Wang M, Castellano-Sanchez A, Khan J, Polak MA, Glass JD. 2004. Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp Neurol 185:232-240.
17. Frei R, Motzing S, Kinkelin I, Schachner M, Koltzenburg M, Martini R. 1999. Loss of distal axons and sensory Merkel cells and features indicative of muscle denervation in hindlimbs of P0-deficient mice. J Neurosci 19:6058-6067.
18. Gabreels-Festen AA, Hoogendijk JE, Meijerink PH, Gabreels FJ, Bolhuis PA, van Beersum S, Kulkens T, Nelis E, Jennekens FG, de Visser M, van Engelen BG, Van Broeckhoven C, Mariman EC. 1996. Two divergent types of nerve pathology in patients with different P0 mutations in Charcot-Marie-Tooth disease. Neurology 47:761-765.
19. Garbern JY, Yool DA, Moore GJ, Wilds IB, Faulk MW, Klugmann M, Nave KA, Sistermans EA, van der Knaap MS, Bird TD, Shy ME, Kamholz JA, Griffiths IR. 2002. Patients lacking the major CNS myelin protein, proteolipid protein 1, develop length-dependent axonal degeneration in the absence of demyelination and inflammation. Brain 125:551-561.
20. Goldberg AL. 2003. Protein degradation and protection against misfolded or damaged proteins. Nature 426:895-899.
21. Griffiths I, Klugmann M, Anderson T, Yool D, Thomson C, Schwab MH, Schneider A, Zimmermann F, McCulloch M, Nadon N, Nave KA. 1998. Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. Science 280:1610-1613.
22. Hanemann CO, Gabreels-Festen AA, De Jonghe P. 2001. Axon damage in CMT due to mutation in myelin protein P0. Neuromuscul Disord 11:753-756.
23. Hayasaka K, Himoro M, Wang Y, Takata M, Minoshima S, Shimizu N, Miura M, Uyemura K, Takada G. 1993. Structure and chromosomal localization of the gene encoding the human myelin protein zero (MPZ). Genomics 17:755-758.
24. Krajewski KM, Lewis RA, Fuerst DR, Turansky C, Hinderer SR, Garbern J, Kamholz J, Shy ME. 2000. Neurological dysfunction and axonal degeneration in Charcot-Marie-Tooth disease type 1A. Brain 123(Pt 7):1516-1527.
25. Lappe-Siefke C, Goebbels S, Gravel M, Nicksch E, Lee J, Braun PE, Griffiths IR, Nave KA. 2003. Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination. Nat Genet 33:366-374.
26. Leach IH, Tsang ML, Church RJ, Lowe J. 1994. Alpha-B crystallin in the normal human myocardium and cardiac conducting system. J Pathol 173:255-260.
27. Lemke G, Lamar E, Patterson J. 1988. Isolation and analysis of the gene encoding peripheral myelin protein zero. Neuron 1:73-83.
28. Li J, Lewis R, Shy M. 2003. Charcot-Marie-Tooth disease. In: Aminoff M, Daroff R, editors. Encyclopedia of the neurological sciences. New York: Academic Press. p 676-686.
29. Li J, Bai Y, Ghandour K, Qin P, Grandis M, Trostinskaia A, Ianakova E, Wu X, Schenone A, Vallat JM, Kupsky WJ, Hatfield J, Shy ME. 2005. Skin biopsies in myelin-related neuropathies: bringing molecular pathology to the bedside. Brain 128:1168-1177.
30. Lucchinetti CF, Bruck W, Lassmann H. 2004. Evidence for pathogenic heterogeneity in multiple sclerosis. Ann Neurol 56:308.
31. Mandich P, Mancardi GL, Varese A, Soriani S, Di Maria E, Bellone E, Bado M, Gross L, Windebank AJ, Ajmar F, Schenone A. 1999. Congenital hypomyelination due to myelin protein zero Q215X mutation. Ann Neurol 45:676-678.
32. Martini R. 2001. The effect of myelinating Schwann cells on axons. Muscle Nerve 24:456-466.
33. Meijerink PH, Hoogendijk JE, Gabreels-Festen AA, Zorn I, Veldman H, Baas F, de Visser M, Bolhuis PA. 1996. Clinically distinct codon 69 mutations in major myelin protein zero in demyelinating neuropathies. Ann Neurol 40:672-675.
34. Misu K, Yoshihara T, Shikama Y, Awaki E, Yamamoto M, Hattori N, Hirayama M, Takegami T, Nakashima K, Sobue G. 2000. An axonal form of Charcot-Marie-Tooth disease showing distinctive features in association with mutations in the peripheral myelin protein zero gene (Thr124Met or Asp75Val). J Neurol Neurosurg Psychiatry 69:806-811.
35. Neuberg DH, Sancho S, Suter U. 1999. Altered molecular architecture of peripheral nerves in mice lacking the peripheral myelin protein 22 or connexin32. J Neurosci Res 58:612-623.
36. Nolano M, Provitera V, Crisci C, Stancanelli A, Wendelschafer-Crabb G, Kennedy WR, Santoro L. 2003. Quantification of myelinated endings and mechanoreceptors in human digital skin. Ann Neurol 54:197-205.
37. Pan B, Fromholt SE, Hess EJ, Crawford TO, Griffin JW, Sheikh KA, Schnaar RL. 2005. Myelin-associated glycoprotein and complementary axonal ligands, gangliosides, mediate axon stability in the CNS and PNS: neuropathology and behavioral deficits in single- and double-null mice. Exp Neurol 195:208-217.
38. Raff MC, Whitmore AV, Finn JT. 2002. Axonal self-destruction and neurodegeneration. Science 296:868-871.
39. Rasband MN, Shrager P. 2000. Ion channel sequestration in central nervous system axons. J Physiol 525(Pt 1):63-73.
40. Rasband MN, Taylor CM, Bansal R. 2003. Paranodal transverse bands are required for maintenance but not initiation of Nav1.6 sodium channel clustering in CNS optic nerve axons. Glia 44:173-182.
41. Rios JC, Melendez-Vasquez CV, Einheber S, Lustig M, Grumet M, Hemperly J, Peles E, Salzer JL. 2000. Contactin-associated protein (Caspr) and contactin form a complex that is targeted to the paranodal junctions during myelination. J Neurosci 20:8354-8364.
42. Ross CA, Poirier MA. 2004. Protein aggregation and neurodegenerative disease. Nat Med 10(Suppl):S10-S17.
43. Scherer SS, Arroyo EJ. 2002. Recent progress on the molecular organization of myelinated axons. J Peripher Nerv Syst 7:1-12.
44. Schmid CD, Stienekemeier M, Gehen S, Bootz F, Zielasek J, Gold R, Toyka KV, Schachner M, Martini R. 2000. Immune deficiency in mouse models for inherited peripheral neuropathies leads to improved myelin maintenance. J Neurosci 20:729-735.
45. Senderek J, Bergmann C, Quasthoff S, Ramaekers VT, Schroder JM. 1998. X-linked dominant Charcot-Marie-Tooth disease: nerve biopsies allow morphological evaluation and detection of connexin32 mutations (Arg15Trp, Arg22Gln). Acta Neuropathol (Berl) 95:443-449.
46. Shapiro L, Doyle JP, Hensley P, Colman DR, Hendrickson WA. 1996. Crystal structure of the extracellular domain from P0, the major structural protein of peripheral nerve myelin. Neuron 17:435-449.
47. Shy ME, Arroyo E, Sladky J, Menichella D, Jiang H, Xu W, Kamholz J, Scherer SS. 1997. Heterozygous P0 knockout mice develop a peripheral neuropathy that resembles chronic inflammatory demyelinating polyneuropathy (CIDP). J Neuropathol Exp Neurol 56:811-821.
48. Shy ME, Jani A, Krajewski K, Grandis M, Lewis RA, Li J, Shy RR, Balsamo J, Lilien J, Garbern JY, Kamholz J. 2004. Phenotypic clustering in MPZ mutations. Brain 127:371-384.
49. Takashima H, Boerkoel CF, De Jonghe P, Ceuterick C, Martin JJ, Voit T, Schroder JM, Williams A, Brophy PJ, Timmerman V, Lupski JR. 2002. Periaxin mutations cause a broad spectrum of demyelinating neuropathies. Ann Neurol 51:709-715.
50. Tan Z, Tu W, Schreiber SS. 2001. Downregulation of free ubiquitin: a novel mechanism of p53 stabilization and neuronal cell death. Brain Res Mol Brain Res 91:179-188.
51. Trapp BD, Webster HD, Johnson D, Quarles RH, Cohen SR, Murray MR. 1982. Myelin formation in rotation-mediated aggregating cell cultures: immunocytochemical, electron microscopic, and biochemical observations. J Neurosci 2:986-993.
52. Ulzheimer JC, Peles E, Levinson SR, Martini R. 2004. Altered expression of ion channel isoforms at the node of Ranvier in P0-deficient myelin mutants. Mol Cell Neurosci 25:83-94.
53. Vital C, Vital A, Bouillot S, Favereaux A, Lagueny A, Ferrer X, Brechenmacher C, Petry KG. 2003. Uncompacted myelin lamellae in peripheral nerve biopsy. Ultrastruct Pathol 27:1-5.
54. Warner LE, Hilz MJ, Appel SH, Killian JM, Kolodry EH, Karpati G, Carpenter S, Watters GV, Wheeler C, Witt D, Bodell A, Nelis E, Van Broeckhoven C, Lupski JR. 1996. Clinical phenotypes of different MPZ (P0) mutations may include Charcot-Marie-Tooth type 1B, Dejerine-Sottas, and congenital hypomyelination. Neuron 17:451-460.
55. Watanabe M, Yamamoto N, Ohkoshi N, Nagata H, Kohno Y, Hayashi A, Tamaoka A, Shoji S. 2002. Corticosteroid-responsive asymmetric neuropathy with a myelin protein zero gene mutation. Neurology 59:767-769.
56. Yin X, Crawford TO, Griffin JW, Tu P, Lee VM, Li C, Roder J, Trapp BD. 1998. Myelin-associated glycoprotein is a myelin signal that modulates the caliber of myelinated axons. J Neurosci 18:1953-1962.
57. Yin X, Kidd GJ, Wrabetz L, Feltri ML, Messing A, Trapp BD. 2000. Schwann cell myelination requires timely and precise targeting of P(0) protein. J Cell Biol 148:1009-1020.
58. Yoshikawa H, Dyck PJ. 1991. Uncompacted inner myelin lamellae in inherited tendency to pressure palsy. J Neuropathol Exp Neurol 50:649-657.
59. Zhai Q, Wang J, Kim A, Liu Q, Watts R, Hoopfer E, Mitchison T, Luo L, He Z. 2003. Involvement of the ubiquitin-proteasome system in the early stages of wallerian degeneration. Neuron 39:217-225.